Count | |
1 | |
10 | |
7 | |
2 | |
1 | |
1 | |
1 | |
12 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
2 | |
Heparin, Low-Molecular-Weight/*adverse effects/therapeutic use | 1 |
Heparin/administration & dosage/*adverse effects/therapeutic use | 1 |
Heparin, Low-Molecular-Weight/adverse effects/*therapeutic use | 2 |
Heparin, Low-Molecular-Weight/*administration & dosage/adverse effects | 1 |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
Butyrylcholinesterase/adverse effects/*immunology/*pharmacokinetics | 1 |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
3 | |
1 | |